EUCTR2005-005661-11-IT
Active, not recruiting
Not Applicable
PHASE II STUDY OF NEOADJUVANT CHEMORADIOTHERAPY IN LOCALLY ADVANCED RECTAL CANCER - XELOXART
AZIENDA SANITARIA OSPEDALIERA S. GIOVANNI BATTISTA DI TORINO0 sitesSeptember 7, 2007
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- rectal cancer
- Sponsor
- AZIENDA SANITARIA OSPEDALIERA S. GIOVANNI BATTISTA DI TORINO
- Status
- Active, not recruiting
- Last Updated
- 14 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\) Locally advanced rectal cancer (T3\-4 and / or N\+)
- •2\) PS 0\-1 WHO
- •3\) 18\-75 years age
- •4\) written informed consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1\.2 Adults (18\-64 years) yes
- •F.1\.2\.1 Number of subjects for this age range
- •F.1\.3 Elderly (\>\=65 years) yes
- •F.1\.3\.1 Number of subjects for this age range
Exclusion Criteria
- •1\) Controindications to surgery
- •2\) Previous oncological therapies
- •3\) Previous malignant tumors (a part skin cancer)
- •4\) Rectal cancer responsible of severe stenosis or significant bleeding
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Phase II study of neoadjuvant chemoradiotherapy of s-1 and cisplatin for advanced gastric cancer with lymph node metastases (Neo-KOGC04 study)Advanced Gastric CancerJPRN-UMIN000014331School of Medicine, Keio University30
Not yet recruiting
Not Applicable
eoadjuvant chemoradiotherapy with protons for resectable esophageal cancerKCT0005576ational Cancer Center68
Recruiting
Phase 1
Phase I, II study of neoadjuvant chemotherapy with gemcitabine and nab-paclitaxel for resectable pancreatic cancerpancreatic ductal cancerJPRN-jRCTs021200003Ishido Keinosuke30
Recruiting
Phase 2
A phase II study of neoadjuvant chemotherapy with S-1 and oxaliplatin followed by surgery in cStageIII advanced gastric cancer patientsJPRN-UMIN000023405Wakayama Medical University, Second Department of Surgery48
Completed
Phase 1
PhaseI/II trial of neoadjvant chemoradiotherapy with docetaxel,CDDP and 5-Fluorouracil followed by surgery in patients with advanced esophageal cancer.Esophageal CancerJPRN-UMIN000002137Department of Surgical Oncology, Division of Clinical and Experimental Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University40